Articles/ Pharma Market Access/ UK & Europe/ Views and analysis Unstable and unpredictable? The reality of the PPRS Leela Barham Department of Health, DH, Drug pricing, Leela Barham, Pharmaceutical Price Regulation Scheme, PPRS 0 Comment Has the UK PPRS scheme met its five objectives? Share X Unstable and unpredictable? The reality of the PPRS https://pharmaphorum.com/views-and-analysis/pprs-pharmaceutical-price-regulation-scheme/
Articles/ Healthcare/ Pharma Market Access/ UK & Europe/ Views and analysis The rise and fall of PPRS payments Leela Barham Department of Health, DH, Drug pricing, Health budget, NHS, PPRS, UK pharma 0 Comment How contributions from the updated PPRS have affected the DH budget for the NHS. Share X The rise and fall of PPRS payments https://pharmaphorum.com/views-and-analysis/rise-fall-pprs-payments/
News/ Pharma Market Access/ UK & Europe UK government hires ex-pharma chief to lead pricing talks with industry Andrew McConaghie ABPI, Department of Health, DH, PPRS, UK pharma 0 Comment The Department of Health has appointed a former UK head of Sanofi and Teva to be its chief Share X UK government hires ex-pharma chief to lead pricing talks with industry https://pharmaphorum.com/news/uk-government-hires-ex-pharma-chief-steve-oldfield/
Articles/ Pharma Market Access/ UK & Europe/ Views and analysis Sitting uncomfortably? The UK’s PPRS and statutory schemes Leela Barham Department of Health, DH, Drug pricing, Leela Barham, pharma, PPRS 0 Comment Do the PPRS and the statutory scheme run effectively in parallel? Share X Sitting uncomfortably? The UK’s PPRS and statutory schemes https://pharmaphorum.com/views-and-analysis/sitting-uncomfortably-uks-pprs-statutory-schemes/